Umasons Pharma Private Limited - Due diligence report

A 360° intelligence report on Umasons Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

1996-07-02 Jaipur, Rajasthan Active Unlisted Active Non-Compliant
Share
Connect MCP
UP Umasons Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Umasons Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
50/100
Trust Score
Moderate

Umasons Pharma Private Limited is assessed as Moderate with a Trust Score of 50/100. Umasons Pharma Private Limited is an active private limited indian non-government company incorporated in 1996, operating in the Chemicals and Materials sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 12 Aug 2026 from the latest processed filings. Umasons Pharma Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Neutral
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
50/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
48/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).

Charges position: 1 open (10.00 Lakh) · 1 satisfied (83.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Uco Bank1 48.0 cr
The Rajputana Mahila Urban Co-Op Bank Ltd1 48.0 cr
Compliance Score: 48/100 Caution Indicated
  • Company status is Active as per MCA.
  • Marked ACTIVE non-compliant (INC-22A).
  • Last balance sheet is for Mar 2016 - filings overdue.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
CHANDER SEN DATWANI 01234567 Director 01/04/2018 6 yrs Approved
HARSHA DATWANI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • CHANDER SEN DATWANI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2016)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2016 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 50
Growth signals & trust indicators
Operating for 30+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (48/100).
1 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence49/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment28/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 10.00 Lakh already registered.
  • Compliance gaps should be priced into terms.
Investor view37/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 10 events
30 Sep 2016
Last AGM held
Annual general meeting
16 Jun 2016
Charge satisfied
Uco Bank
31 Mar 2016
Latest balance sheet
Filed with ROC
29 Sep 2012
Director ceased
HARSHA DATWANI
18 Aug 2012
Director appointed
HARSHA DATWANI (Director)
Director ceased
SURESH DATWAN
28 Jun 2002
Charge created
Uco Bank - 83.00 Lakh
10 Jan 2002
Charge created
The Rajputana Mahila Urban Co-Op Bank Ltd - 10.00 Lakh
02 Jul 1996
Incorporated
Registered with Roc Jaipur
Director appointed
CHANDER SEN DATWANI (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 3 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
Promoters hold a dominant controlling stake as per the FY 2016 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
A. H. Project Private Limited U45400WB2010PTC141970 Kolkata, West Bengal, India
Shyambaba Distributors Pvt Ltd U51109WB2006PTC107767 Kolkata, West Bengal, India
Vikas Decowoods Private Limited U51102DL2008PTC178116 Delhi, Delhi, India
Madhuri Dresses Private Limited U18101DL2006PTC155281 New Delhi, Delhi, India
Beriwal Exim Private Limited U74999DL2008PTC179546 Delhi, Delhi, India
Aindro Pharmaceuticals Private Limited U24231TN2001PTC047374 Chennai, Tamil Nadu, India
Javid Tradings Private Limited. U51909JK2008PTC002958 Srinagar, Jammu & Kashmir, India
Pardeep Ispat Private Limited U28121HR2012PTC044813 Sirsa, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Umasons Pharma Private Limited before audits and certifications: compliance score 48/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Umasons Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Umasons Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 50/100, distress signals and MSME payment-delay disclosures - know whether Umasons Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Umasons Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Umasons Pharma Private Limited an active company?

Umasons Pharma Private Limited has MCA status “Active” with a compliance score of 48/100 (Caution Indicated).

Is Umasons Pharma Private Limited financially healthy?

Umasons Pharma Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Umasons Pharma Private Limited?

Its overall Trust Score is 50/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Umasons Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Umasons Pharma Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Umasons Pharma Private Limited up to date with its ROC filings?

Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 48/100 (Caution Indicated).

Is it risky to lend to Umasons Pharma Private Limited?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.